↓ Skip to main content

Abemaciclib plus fulvestrant for the treatment of hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer with cystic brain metastases: A case report and literature…

Overview of attention for article published in Frontiers in oncology, November 2022
Altmetric Badge

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
5 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Abemaciclib plus fulvestrant for the treatment of hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer with cystic brain metastases: A case report and literature review
Published in
Frontiers in oncology, November 2022
DOI 10.3389/fonc.2022.984454
Pubmed ID
Authors

Zhaohui Chu

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 5 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 5 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 1 20%
Student > Master 1 20%
Unknown 3 60%
Readers by discipline Count As %
Social Sciences 1 20%
Neuroscience 1 20%
Unknown 3 60%